Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$523,601
+$23,803 QoQ
Shares Held
3,341
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#863
of 1,603 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LCM Capital Management Inc holds $6,711,620 across 8 Drug Manufacturers - General names. NVS ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,695 | $2,716,209 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
8,991 | $1,135,922 | |
| 3 | AMRN |
Amarin Corp Plc\Uk
|
51,362 | $818,710 | |
| 4 | NVS |
Novartis AG
This page
|
3,341 | $523,601 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,930 | $514,546 | |
| 6 | AMGN |
Amgen Inc
|
997 | $361,033 | |
| 7 | PFE |
Pfizer Inc
|
14,441 | $347,739 | |
| 8 | LLY |
ELI LILLY & Co
|
245 | $293,860 |
All Filings in NVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $523,601 | 3,341 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $499,798 | 3,272 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $443,252 | 3,215 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $413,830 | 3,227 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $399,454 | 3,301 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $369,890 | 3,318 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $317,230 | 3,260 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $374,390 | 3,255 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $340,884 | 3,202 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $301,410 | 3,116 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $313,007 | 3,100 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $313,932 | 3,082 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $298,088 | 2,954 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $265,512 | 2,886 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $246,123 | 2,713 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $205,379 | 2,702 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $229,245 | 2,712 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $239,733 | 2,732 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $234,682 | 2,683 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $209,765 | 2,565 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $233,574 | 2,560 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $215,922 | 2,526 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $247,595 | 2,622 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||